Re-expression of cell adhesion molecule inhibits growth and induces apoptosis of human pancreatic cancer cell line PANC-1

Abstract

This study examined the expression of cell adhesion molecule 1 (CADM1) in pancreatic cancer and the possible mechanism. The expression of CADM1 was detected by immunohistochemistry in tissues of pancreatic cancer, pancreatitis, and normal pancreas. The plasmid pcDNA3.1-Hygro(+)/CADM1 was transfected into PANC-1 cells (a pancreatic cancer cell line). The expression of CADM1 in the transfected cells was determined by RT-PCR and Western blotting. Cell growth was measured by the MTT method and cell apoptosis by flow cytometry. The results showed that CADM1 was weakly expressed in tissues of pancreatic cancer in contrast to its high expression in normal pancreatic and pancreatitis tissues. The expression level of CADM in pancreatic caner was intensely correlated with the differentiation degree, lymph node metastasis and TNM stages. The growth of CADM1-transfected PANC-1 cells was significantly suppressed in vitro by a G1 cell cycle arrest and apoptosis occurrence. It was concluded that re-expression of CADM1 inhibits the growth of pancreatic cancer cells and induces their apoptosis in vitro. As a tumor suppressor gene, CADM1 plays an important role in the occurrence, progression and metastasis of pancreatic cancer.

Keywords

pancreatic cancer / tumor suppressor gene / cell adhesion molecule 1 / PANC-1

References

[1] KuramochiM., FukuharaH., NobukuniT., et al.. TSLC1 is a tumor suppressor gene in human non-small cell lung cancer. Nat Genet, 2001, 27(4): 427-430

[2] FukuharaH., MasudaM., YagetaM., et al.. Association of a lung tumor suppressor TSLC1 with MPP3, a human homologue of drosophila tumor suppressor Dlg. Oncogene, 2003, 22(40): 6160-6165

[3] MaoX., SeidlitzE., TruantR., et al.. Re-expression of TSLC1 in a non-small-cell lung cancer cell line induces apoptosis and inhibits tumor growth. Oncogene, 2004, 23(33): 5632-5642

[4] Sakurai-YagetaM., MasudaM., TsuboiY., et al.. Tumor suppressor CADM1 is involved in epithelial cell structure. Biochem Biophys Res Commun, 2009, 390(3): 977-982

[5] TakaiY., IrieK., ShimizuK., et al.. Nectins and nectin-like molecules. Roles in cell adhesion, migration, and polarization. Cancer Sci, 2003, 94(8): 655-667

[6] JemalA., ThomasA., MurrayT., et al.. Cancer statistics, 2002. CA Cancer J Clin, 2002, 52(1): 23-47

[7] JansenM., FukushimaN., RostyC., et al.. Aberrant methylation of the 5′ CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanINs. Cancer Biol Ther, 2002, 1(3): 293-296

[8] GreeneF.L.. . American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging manual, 20026th ed.New York, Springer Co.

[9] GotoA., NikiT., Chi-pinL., et al.. Loss of TSLC expression in lung adenocarcinoma: Relationships with histological subtypes, sex and prognostic significance. Cancer Sci, 2005, 96(8): 480-486

[10] MurakamiY.. Functional cloning of a tumor suppressor gene, TSLC1, in human non-small cell lung cancer. Oncogene, 2002, 21(45): 6936-6948

[11] AllinenM., PeriL., KujalaS., et al.. Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer: indications of TSLC1 promoter hypermethylation. Genes Chromosomes Cancer, 2002, 34(4): 384-389

[12] ItoT., ShimadaY., HashimotoY., et al.. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma. Cancer Res, 2003, 63(19): 6320-6326

[13] HondaT., TamuraG., WakiT., et al.. Hypermethylation of the TSLC1 gene promoter in primary gastric cancers and gastric cancer cell lines. Jpn J Cancer Res, 2002, 93(8): 857-860

[14] HuiA.B., LoK.W., KwongJ., et al.. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma. Mol Carcinog, 2003, 38(4): 170-178

[15] SteenbergenR.D., KramerD., BraakhuisB.J., et al.. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia. J Natl Cancer Inst, 2004, 96(4): 294-305

[16] FukuharaH., KuramochiM., FukamiT., et al.. Promoter methylation of the TSLC1 and tumor suppression by its gene product in human prostate cancer. Jpn J Cancer Res, 2002, 93(6): 605-609

[17] SuraceE.I., MurakamiY., ScheithauerB.W., et al.. Tumor suppressor in lung cancer-1 (TSLC1) expression is lost in sporadic meningioma. J Neuropathol Exp Neurol, 2004, 63(10): 1015-1027

[18] ChenK., WangG., PengL., et al.. CADM1/TSLC1 inactivation by promoter hypermethylation is a frequent event in colorectal carcinogenesis and correlates with late stages of the disease. Int J Cancer., 2011, 128(2): 266-273

[19] FukamiF., FukuharaH., KuramochiM., et al.. Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines. Int J Cancer, 2003, 107(1): 53-59

[20] OvermeerR.M., HenkenP.E., SnijdersP.J., et al.. Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC. J Pathol, 2008, 215(4): 388-397

[21] MingS., GaoJ., SunT.. The relationship between the TSLC1 silencing and DNA methylation in human lung cancer cells. Zhongguo Fei Ai Za Zhi (Chinese), 2010, 13(5): 464-469

[22] UchinoK., ItoA., WakayamaT., et al.. Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung. Cancer, 2003, 98(5): 1002-1007